Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Public ClinicalTrials.gov record NCT02469246. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Randomized, Double-Blind, Switch Study to Evaluate F/TAF in HIV-1 Infected Subjects Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objectives of this study are to evaluate the efficacy, safety, and tolerability of switching abacavir/lamivudine (ABC/3TC) fixed-dose combination (FDC) tablets to emtricitabine/tenofovir alafenamide (F/TAF) FDC tablets versus maintaining ABC/3TC in human immunodeficiency virus type 1 (HIV-1) infected adults who are virologically suppressed on regimens containing ABC/3TC.
Study identification
- NCT ID
- NCT02469246
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 567 participants
Conditions and interventions
Conditions
Interventions
- F/TAF Drug
- ABC/3TC Drug
- ABC/3TC Placebo Drug
- F/TAF Placebo Drug
- 3rd ARV agent Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 29, 2015 (Actual)
- Primary completion
- Dec 11, 2017 (Actual)
- Completion
- Mar 13, 2019 (Actual)
- Last update posted
- Oct 25, 2019
2015 – 2019
United States locations
- U.S. sites
- 34
- U.S. states
- 17
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Spectrum Medical Group | Phoenix | Arizona | — | — |
| Pacific Oaks Medical Group | Beverly Hills | California | — | — |
| University of California San Diego (UCSD) | La Jolla | California | — | — |
| Anthony Mills, MD, Inc. | Los Angeles | California | — | — |
| Peter J. Ruane, MD, Inc. | Los Angeles | California | — | — |
| Highland Hospital - Alameda Health System | Oakland | California | — | — |
| La Playa Medical Group and Clinical Research | San Diego | California | — | — |
| Capial Medical Associates | Washington D.C. | District of Columbia | — | — |
| Dupont Circle Physician's Group | Washington D.C. | District of Columbia | — | — |
| Whitman-Walker Health | Washington D.C. | District of Columbia | — | — |
| Gary J. Richmond,M.D.,P.A. | Fort Lauderdale | Florida | — | — |
| Therafirst Medical Center | Fort Lauderdale | Florida | — | — |
| Midway Immunology and Research Center | Ft. Pierce | Florida | — | — |
| Orlando Immunology Center | Orlando | Florida | — | — |
| Triple O Research Institute PA | West Palm Beach | Florida | — | — |
| Atlanta ID Group | Atlanta | Georgia | — | — |
| Howard Brown Health Center | Chicago | Illinois | — | — |
| University of Louisville | Louisville | Kentucky | — | — |
| LSU Health Sciences Center | New Orleans | Louisiana | — | — |
| Be Well Medical Center | Berkley | Michigan | — | — |
| Hennepin County Medical Center | Minneapolis | Minnesota | — | — |
| The KC CARE Clinic | Kansas City | Missouri | — | — |
| Southampton Healthcare, Inc. | St Louis | Missouri | — | — |
| Saint Michael's Medical Center | Newark | New Jersey | — | — |
| South Jersey Infectious Disease | Somers Point | New Jersey | — | — |
| Southwest CARE Center | Santa Fe | New Mexico | — | — |
| Montefiore Medical Center | The Bronx | New York | — | — |
| Philadelphia FIGHT | Philadelphia | Pennsylvania | — | — |
| Central Texas Clinical Research | Austin | Texas | — | — |
| AIDS Arms, Inc | Dallas | Texas | — | — |
| Tarrant County Infectious Disease Associates | Fort Worth | Texas | — | — |
| Gordon E. Crofoot MD PA | Houston | Texas | — | — |
| Therapeutic Concepts, PA | Houston | Texas | — | — |
| Peter Shalit, MD | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02469246, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 25, 2019 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02469246 live on ClinicalTrials.gov.